Cargando…
Recovery following Thyroxine Treatment Withdrawal, but Not Propylthiouracil, Averts In Vivo and Ex Vivo Thyroxine-Provoked Cardiac Complications in Adult FVB/N Mice
Persistent cardiovascular pathology has been described in hyperthyroid patients even with effective antithyroid treatment. Here, we studied the effect of a well-known antithyroid drug, propylthiouracil (PTU; 20 mg/kg/day), on thyroxine (T4; 500 µg/kg/day)-induced increase in blood pressure (BP), car...
Autores principales: | Saad, Nancy S., Repas, Steven J., Floyd, Kyle, Janssen, Paul M. L., Elnakish, Mohammad T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5534272/ https://www.ncbi.nlm.nih.gov/pubmed/28791308 http://dx.doi.org/10.1155/2017/6071031 |
Ejemplares similares
-
The Effect of Sorafenib, Tadalafil and Macitentan Treatments on Thyroxin-Induced Hemodynamic Changes and Cardiac Abnormalities
por: Saad, Nancy S., et al.
Publicado: (2016) -
Thyroxine (T4) may promote re-epithelialisation and angiogenesis in wounded human skin ex vivo
por: Zhang, Guo-You, et al.
Publicado: (2019) -
Efficacy and Safety of Once-Weekly Thyroxine for Thyroxine-Resistant Hypothyroidism
por: Jayakumari, Chellama, et al.
Publicado: (2019) -
Thyroxine and Free Thyroxine Levels in Workers Occupationally Exposed to Inorganic Lead
por: Bledsoe, Michael L., et al.
Publicado: (2011) -
Thyroxine: Recent Research
Publicado: (1926)